BUR1

CAS No. 23000-46-6

BUR1 ( BUR-1; BUR 1; BMP upregulator 1; BMP upregulator-1 )

Catalog No. M27759 CAS No. 23000-46-6

BUR1 is a Saccharomyces cerevisiae cyclin-dependent kinase (CDK) and is homologous to mammalian Cdk9, which functions in transcriptional elongation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 302 Get Quote
10MG 447 Get Quote
25MG 714 Get Quote
50MG 1017 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BUR1
  • Note
    Research use only, not for human use.
  • Brief Description
    BUR1 is a Saccharomyces cerevisiae cyclin-dependent kinase (CDK) and is homologous to mammalian Cdk9, which functions in transcriptional elongation.
  • Description
    BUR1 is a Saccharomyces cerevisiae cyclin-dependent kinase (CDK) and is homologous to mammalian Cdk9, which functions in transcriptional elongation.
  • Synonyms
    BUR-1; BUR 1; BMP upregulator 1; BMP upregulator-1
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    SETD2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    23000-46-6
  • Formula Weight
    279.3
  • Molecular Formula
    C16H17N5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1CCN(CC1)c1ncnc2n(ncc12)-c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jennifer Totman, et al. Pharmacologic Inhibition of the Histone Methyltransferase SETD2 with EZM0414 As a Novel Therapeutic Strategy in Relapsed or Refractory Multiple Myeloma and Diffuse Large B-cell Lymphoma.
molnova catalog
related products
  • BAY-958

    BAY-958 (BAY958, LDC526)is a potent, selective PTEFb/CDK9 inhibitor with IC50 of 5 nM against CDK9/CyclinT1.

  • Bohemine

    Bohemine is a cyclin-dependent kinase inhibitor.

  • Mevociclib

    Mevociclib is a highly selective covalent inhibitor of CDK7. SY-1365 possesses therapeutic potential in both hematological and solid tumors.